FFS
IPSC icon

Founders Financial Securities’s Century Therapeutics IPSC Stock Holding History

Founders Financial Securities’s Portfolio IPSC Stock Details IPSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-10,000
Closed -$10.1K – 483
2024
Q4 		$10.1K Hold
10,000
– – ﹤0.01% 434
2024
Q3 		$17.1K Hold
10,000
– – ﹤0.01% 424
2024
Q2 		$25.5K Hold
10,000
– – ﹤0.01% 417
2024
Q1 		$41.8K Hold
10,000
– – ﹤0.01% 380
2023
Q4 		$33.2K Buy
+10,000
New +$18.2K ﹤0.01% 362

Other funds holding IPSC

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
SP
Syncona Portfolio St Peter Port, Guernsey $25.7M AUM 13.32% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Founders Financial Securities's IPSC Position: Q1 2025 in Review

Founders Financial Securities sold out of Century Therapeutics (IPSC) in Q1 2025, closing a stake of 10,000 shares — an estimated $10.1K sold.

Founders Financial Securities first reported a position in IPSC in Q4 2023 and held it in 5 quarters. The position peaked at $41.8K in Q1 2024. 70 funds tracked by Wall St. Rank hold IPSC as of Q1 2025.

  • Founders Financial Securities reported no remaining Century Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Founders Financial Securities sold 10,000 Century Therapeutics shares in Q1 2025, an estimated $10.1K.
  • Founders Financial Securities first reported a position in Century Therapeutics in Q4 2023 and held it in 5 quarters.
  • Founders Financial Securities's Century Therapeutics position peaked at $41.8K in Q1 2024.
  • 70 funds tracked by Wall St. Rank held Century Therapeutics as of Q1 2025.

Based on Founders Financial Securities's 13F filing for Q1 2025, filed 12 May 2025.